Clinical Trials
2 trialsNCT07458919 2026-03-09
Therapy for Advanced NSCLC With EGFR 19delins Mutation
Fuzhou General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT05263947 2026-02-24
Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed